Dr. Sankar Bandyopadhyay, MD

Dr. Bandyopadhyay practices at OSF St Francis Medical Center & Children's Hospital of Illinois in Peoria, Illinois.

Dr. Bandyopadhyay's NPI, 1821088329, was assigned on October 26, 2005. Dr. Bandyopadhyay holds Pennsylvania license MD447406.

Dr. Bandyopadhyay's primary practice is OSF St Francis Medical Center & Children's Hospital of Illinois, at 530 NE Glen Oak Ave, Peoria, IL 61603 in Peoria County. The practice phone is (309) 655-2000.

Dr. Bandyopadhyay's primary practice is OSF St Francis Medical Center & Children's Hospital of Illinois in Peoria, Illinois. Dr. Bandyopadhyay is also affiliated with OSF Saint Francis Medical Center. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Bandyopadhyay to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bandyopadhyay practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bandyopadhyay's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Bandyopadhyay's licenses on file in 2 states: Pennsylvania and Wisconsin.

CMS data shows 310 Medicare services from Dr. Bandyopadhyay across 10 procedure codes in 2024, for 171 Medicare patients. Medicare paid $16,386 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Bandyopadhyay in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bandyopadhyay's median patient age at 66, with 54% women.

In 2024, Dr. Bandyopadhyay wrote 462 Medicare Part D claims for 48 patients. 78% of them were for generic drugs. CMS names the drug for 417 of them, across 7 drugs with 11 or more claims each, at $1,205,098 in total drug cost. In 2023, CMS named 349 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bandyopadhyay for performance year 2024, reported as part of a group. Dr. Bandyopadhyay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Bandyopadhyay from 3 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $172.